Welcome to WisconsinLifeScience.com
WisconsinLifeScience.com is part of a specialized network of state- and province-based biotechnology, medical device,
and life science sites that includes more than 4,500 biotechnology, medical device, pharmaceutical companies,
non-profit research institutions, universities and supporting service sector companies across the U.S. and Canada.
This network addresses the growing informational and service needs of companies, patients, educators and others in
their respective states while providing clients the opportunity to cost effectively
advertise their job openings, events, facility availability and other services at the state level,
regionally or nationwide. We welcome your comments, suggestions and requests for informational content and supporting
services.
 More...
Destination Wisconsin
Are you considering a move to Wisconsin? Relocating your business to
Wisconsin? Starting a company? Or just interested in Wisconsin?
This section will answer many of your questions regarding the life science industry in Wisconsin, the province's
economy, tax structure and cost of living, education, transportation, climate, recreational opportunities, history,
industry resources, and more.
More...
|
|
|
Local News...
Free News Release Posting & Archiving Service
- Court in Denmark upholds two Lipitor patents, prevents launch of Ranbaxy generic product Pfizer said that the Eastern Division of the High Court in Copenhagen, Denmark has ruled in the company's favor in challenges to two of its patents covering atorvastatin, the active ingredient in Lipitor. The basic and enantiomer patents were challenged by generics manufacturer Ranbaxy.
Pfizer Inc. August 29, 2008
- Aastrom Biosciences reports fourth quarter and fiscal year 2008 financial results Aastrom Biosciences reported financial results for the fourth quarter and fiscal year ended June 30, 2008. Total revenues for the quarter and twelve months ended June 30, 2008 were $149,000 and $522,000, respectively, compared to $165,000 and $685,000 for the same periods in fiscal year 2007.
Aastrom Biosciences, Inc. August 29, 2008
- GSK signs $820M drug development deal GlaxoSmithKline has signed a drug development deal worth as much as $820 million with California company Valeant Pharmaceuticals. Under terms of the deal, Valeant gives GlaxoSmithKline the worldwide development and commercialization rights to the drug retigabine.
Triangle Business Journal August 28, 2008
- The CYPHER(R) Stent outperforms the Taxus(R) Stent in people with diabetes In patients with diabetes, the CYPHER(R) Sirolimus-eluting Coronary Stent outperformed the Taxus(R) Stent with lower rates of in-segment restenosis, target lesion revascularization and major adverse events at nine months according to clinical data.
Johnson & Johnson August 28, 2008
- Monsanto and Evogene collaborate on yield and stress research Monsanto Company and Evogene have entered into a five-year research and development collaboration focused on identifying key plant genes related to yield, environmental stress and fertilizer utilization.
Monsanto Company August 28, 2008
More... | Submit News Release | National News
|
New Job Postings...
Free Job Posting Trial Offer
More... |
Job Advertising...
| About Job Postings...
|
New Facilities Available...
ATC clean room constructors...validation guaranteed!
More... |
Facility Advertising...
|
Upcoming Events...
Free Event Posting Service
 More... |
Submit Event |
Event Advertising...
|
|
Learn About Wisconsin's BioHistory
Why is there a biotechnology industry in Wisconsin? Will the industry continue
to grow in Wisconsin? What do other states have? Each state has a unique story
that explains why a given industry has developed in a specific region and not in others.
Through Wisconsin BioHistory, you can learn about the scientists,
institutions, political leaders, and significant events that have shaped and are still shaping
the biotechnology, medical device and life science industries in the state of Wisconsin.
More...
BioEvolution Posters
More...
Your Guide to Reporting Problems to FDA
Consumers play an important public health role by reporting to the Food and
Drug Administration (FDA) any adverse events (unexpected side effects) after
using a medical product, or other problems with any products that the agency
regulates.
Timely reporting allows the agency to take prompt action. There are a
number of ways you can report problems to the agency, depending on the type of
problem and product.
More...
BioFact
(1972) - National Academy of Sciences releases Genetic Vulnerability of Major Crops - a study prompted by the SCLB in 1970 - and the lack of genetic diversity in major crops briefly enjoys media attention and becomes a national issue.
It's a Small World
|
| |
Plant Cells
| |
Science Quote
"Happy is he who gets to know the reasons for things."
| - |
Virgil, Roman poet
|
|
(70-19 BC)
|
|
